Postoperative Pain Market, Market Size and Share, Epidemiology, Market Forecast

Postoperative pain is a normal response to surgical intervention and is a cause of delayed recovery and discharge after surgery or any other operative the procedure, which also leads to increased risk of wound infection.

Untreated pain led to reduced patient satisfaction and increased morbidity and mortality and places a burden on patient finances. It usually lasts less than 3–6 months, and it is directly related to soft tissue damage, and it gradually resolves as the injured tissues heal.

Postoperative Pain Market

DelveInsight's "Postoperative Pain - Market Insights, Epidemiology, and Market Forecast-2030" report delivers an in-depth understanding of the Postoperative Pain, historical and forecasted epidemiology as well as the Postoperative Pain market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Geography Covered

·         The United States

·         EU5 (Germany, France, Italy, Spain, and the United Kingdom)

·         Japan

Postoperative Pain Disease Understanding

The DelveInsight Postoperative Pain market report gives a thorough understanding of the Postoperative Pain by including details such as disease definition, symptoms, causes, pathophysiology, diagnosis and treatment. 

Postoperative Pain Epidemiology  

As per the Delveinsight analysis, the total diagnosed incident cases of postoperative pain in 7MM was found to be 65,109,200 in 2017. Among 7MM, the US reported as the highest number of surgical procedures with 50,393,413 cases in 2017 as per DelveInsight’s estimates. As per DelveInsight, in 2017, it is estimated that the severity-specific incident cases of postoperative pain in France were 1,194,644, 1,439,003, and 828,105 in mild, moderate, and severe cases.

The Postoperative Pain epidemiology division provide insights about historical and current Postoperative Pain patient pool and forecasted trend for every seven major countries. It helps to recognize the causes of current and forecasted trends by exploring numerous studies and views of key opinion leaders. This part of the DelveInsight report also provides the diagnosed patient pool and their trends along with assumptions undertaken.  

Postoperative Pain Market Outlook

The Postoperative Pain treatment pattern consists of different classes of drugs that are classified into pharmacologic and nonpharmacological therapies.

The pharmacological therapies include analgesics that are further segregated into opioids, nonsteroidal anti-inflammatory drugs (NSAIDs), and acetaminophen, respectively. The acute pain is also managed by the use of benzodiazepines, muscle relaxants, antidepressants, alpha-2 agonists, gamma-aminobutyric agonists, and cannabinoids.

Further, nonpharmacological therapies include acupuncture, psychological approaches (cognitive behavioral therapy, mindfulness-based stress reduction), chiropractic manipulation, physical therapy, transcutaneous electrical stimulation, massage therapy, exercise, and other complementary and alternative medicine therapies (CAM).  

The total market of Post-operative Pain in the 7MM was estimated to be USD 1,067.82 Million in 2017.

The Postoperative Pain market outlook of the report helps to build the detailed comprehension of the historic, current, and forecasted Postoperative Pain market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand of better technology. 

According to DelveInsight, Postoperative Pain market in 7MM is expected to change in the study period 2017-2030.

The total Postoperative Pain market size and market size by therapies in Japan is also mentioned. 

Postoperative Pain Drugs Uptake

The current pipeline for postoperative pain holds many significant products, it has few products which are being developed by certain key players, such as Olinvo by Trevena, HTX-011 by Heron Therapeutics, CR845/Difelikefalin by Cara Therapeutics, NTM-001 by Neumentum Pharmaceuticals, and PF-05089771 by Pfizer.

This section focusses on the rate of uptake of the potential drugs recently launched in the Postoperative Pain market or expected to get launched in the market during the study period 2017-2030. The analysis covers Postoperative Pain market uptake by drugs; patient uptake by therapies; and sales of each drug.    

Report Highlights

·         In the coming years, Postoperative Pain market is set to change due to the rising awareness of the disease, and incremental healthcare spending across the world; which would expand the size of the market to enable the drug manufacturers to penetrate more into the market

·         The companies and academics are working to assess challenges and seek opportunities that could influence Postoperative Pain R&D. The therapies under development are focused on novel approaches to treat/improve the disease condition       

·         Major players are involved in developing therapies for Postoperative Pain. Launch of emerging therapies will significantly impact the Postoperative Pain market

·         A better understanding of disease pathogenesis will also contribute to the development of novel therapeutics for Postoperative Pain

·         Our in-depth analysis of the pipeline assets across different stages of development (Phase III and Phase II), different emerging trends and comparative analysis of pipeline products with detailed clinical profiles, key cross-competition, launch date along with product development activities will support the clients in the decision-making process regarding their therapeutic portfolio by identifying the overall scenario of the research and development activities

View detailed report: https://www.delveinsight.com/report-store/postoperative-pain-market

Request to sample pages: https://www.delveinsight.com/sample-request/postoperative-pain-market